Tags Posts tagged with "cnab"

cnab

0 1284
marijuana stocks

Form 8-K for UNITED CANNABIS CORP


22-Dec-2015

Entry into a Material Definitive Agreement, Creation of a Direct Financial O

ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.10% Convertible Promissory Note

On December 16, 2015, United Cannabis Corporation (the “Company”) issued a 10% Convertible Promissory Note to Tangiers Investment Group, LLC, a Delaware limited liability company (the “Buyer”), with a face amount of $500,000 (the “Note”), convertible into shares of common stock of the Company, upon the terms and subject to the limitations and conditions set forth in the Note. The transaction closed on December 16, 2015, and the Note was dated December 9, 2015. In addition, on December 16, 2015, the Company entered into a Security Agreement dated December 11, 2015, with the Buyer granting to the Buyer a security interest in the goods and equipment owned by the Company during the term of the Note.

The payment tranches of the Note mature in one year from each respective funding. The Note bears interest at the rate of 10% per annum, and any amount of the principal or interest on the Note that is not paid when due bears interest at the rate of 20% per annum. The Note also carries a 10% original issue discount.

On December 16,, 2015, the Company received a $220,000 initial funding from the Buyer, less $20,000 in original issue discount, and less $10,000 of debt issuance costs to an unrelated third party so that the Company realized net proceeds of $190,000. The Note carries certain covenants, piggyback registration rights, anti-dilution rights, default rights and redemption rights, all as discussed therein. A copy of the Note is attached hereto as Exhibit 10.1.

Pursuant to the terms of the Note, the Buyer is entitled, at its option, at any time, to convert all or any part of the outstanding and unpaid principal and accrued interest into shares of the Company’s common stock at a price per share equal to 55% of the average of the three lowest closing bid prices during the 10 consecutive trading days ending on the latest complete trading day prior to the conversion date.

The terms of the Note limit the number of shares of Company common stock into which the Note may be converted such that upon conversion, the Buyer and its affiliates may not hold beneficially more than 9.99% of the Company’s outstanding common stock.

The Company claims an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Act”), for the private placement of these securities pursuant to Section 4(2) of the Act and/or Regulation D promulgated thereunder since, among other things, the transaction did not involve a public offering, the Buyer is an accredited investor, the Buyer took the securities for investment and not resale, and the Company took appropriate measures to restrict the transfer of the securities.

Copies of the Note and Security Agreement are filed as Exhibits 4.1 and 10.1, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The foregoing summaries of the terms of the Note and Security Agreement are qualified in their entirety by reference to Exhibits 4.1 and 10.1, respectively.

 

ITEM 2.03 CREATION OF DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.The disclosure in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item.

 

ITEM 3.02 UNREGISTERED SALES OF EQUITY SECURITIES.The information called for by this Item 3.02 is contained in Item 1.01 hereof and incorporated herein by reference.


 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d)

Exhibits.


Exhibit
Number       Description

   4.1       10% Convertible Promissory Note made by United Cannabis Corporation
             in favor of Tangiers Investment Group, LLC dated December 09, 2015

  10.1       Security Agreement dated December 11, 2015, by and between Tangiers
             Investment Group, LLC and United Cannabis Corporation

    1 4673

    Meet Matt McCall & Get His New PREMIUM Feb. 2015 Newsletter Right Now For Free!

    Inside Matt McCall Discusses $CGRW, $CNAB, $OXIS & $OGRMF

    Download By Clicking Here

    About Matt McCall:

    Matt McCall is the founder and president of Penn Financial Group, an investment advisory firm. Matt is also the Managing Editor MarkETForce and FUTR Stocks. Matt has authored two investment books published by Wiley “The Swing Trader’s Bible” and “The Next Great Bull Market”. Matt is also a contributing writer for Benzinga.com. Matt has over 1200 television appearances in the last seven years and is currently a contributor for Fox Business and Fox News Channel. He appears daily as a panelist from 6-7pm ET on Fox Business Network’s “Making Money with Charles Payne”. As a highly sought after speaker, Matt has keynoted investment conferences in the U.S. and Europe over the last decade.

    0 774

    Attention on marijuana stocks has begun to increase since uncertainty last year during midterm elections spawned a consolidation period just before the close of the year.

    As the new outlook for 2015 became more positive for companies in the sector, the January effect has had its way with many of these stocks and several continue to see new highs.   With major investment coming into the industry, there’s no doubt that this will continue to be a topic of interest in the coming year.  Just recently Paypal co-founder Peter Thiel invested in the marijuana industry through a minority stake in Privateer Holdings (through his own fund, The Founders Fund).  Seemingly the marijuana industry’s biggest investor thus far has created a domino effect within the public markets, giving more confidence to otherwise prudent investors.

    Oxis Inernational Inc (OTC:OXIS) recently announced that it had executed a worldwide exclusive patent licensing for certain assets for the treatment of Multiple Myeloma and initiated a consulting agreement with University of Pittsburgh’s Professor, Dr. Xiang-Qun(Sean)Xie.  Dr. Xie is one of the foremost cannabinoid research scientists in the world and boasts a track record of success that’s a mile long.  The license agreement provides Oxis Biotech, Inc an exclusive worldwide license to develop and commercialize therapies for the treatment of Multiple Myeloma.

    Over the last 10 days, OXIS has managed to reach two major and very important milestones, which may have been cause of so much market attention building around this company.  They went from caveat emptor status on OTCMarkets to a Current PinkSheet after getting all of the filings up to date.  Furthermore Oxis entered into this recent licensing agreement.  Since mid-December not only has the stock been on a very consistent upward trend but it has also seen highs of nearly $0.04; coming up from lows of just over a penny.

    Advanced Cannabis Solutions (OTC: CANN) is a service provider to businesses in the cannabis industry.  Recently the company announced that it has signed a Master Services Agreement with New York based Spector Group, one of the nation’s leading architecture, interior design and master planning firms, for the build out of its multi-tenant office building in Denver, to be known as “The Greenhouse.” Robert Frichtel, Chief Executive Officer of ACS, commented, “We are very glad to have Spector Group come on board with this project. As an established and highly experienced firm, we are confident that Spector will bring our vision of The Greenhouse to life quickly and with a minimum of difficulty.”

    Over the last 2 weeks, Advanced Cannabis has been on a warpath for big gains.  The stock opened the year at $1 and has since jumped more than 400% to highs on Tuesday of $4.50. Similar to Oxis just a few weeks ago, Advanced Cannabis is reporting a Caveat Emptor status on OTC Markets.

    United Cannabis Corporation (CNAB) has also come across the radar of many marijuana stock investors.  This month the company announced that it has signed a consulting and licensing agreement with FoxBarry Farms, LLC, whereby FoxBarry will be the exclusive licensee and distributor of United Cannabis branded medical marijuana products in the State of California.

    FoxBarry has earmarked $30 million to fund all phases of the California state-wide program. The Company will receive $200,000 in prepaid royalties for exclusive licensing rights in the State of California and the first location will be located in Northern California; operations are expected to begin in the next 30-45 days.  During the matter of a few days, United Cannabis’ stock price has been on a bull run.  Since opening the year around $0.70, this stock has seen an increase in volume and a jump in price by roughly 91% in the matter of just a few weeks.  Sentiment remains high (no pun intended) across the marijuana sector and these companies have garnered more interest from traders and investors alike.

    About marijuanastocks.com

    MarijuanaStocks.com is the leading web destination for all things cannabis. Investors can find marijuana related financial, medical, legal, and social news anytime day or night. Writers are invited to submit cannabis related articles for publication.

    Legal Disclaimer

    Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. DAMJ VENTURES LLC which owns www.MarijuanaStocks.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.

    DAMJ VENTURES LLC, which owns www.MarijuanaStocks.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. DAMJ VENTURES LLC which owns www.MarijuanaStocks.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.

    Contact Information:

    marijuanastocks.com
    800-539-4313
    pr@marijuanastocks.com


    SOURCE:
    MarijuanaStocks.com

    1 1446

    Form 8-K for UNITED CANNABIS CORP

    7-Jan-2015

    Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financ

    ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.On December 28, 2014, United Cannabis Corporation (the “Company”) executed a Royalty and Consulting Services Agreement with FoxBarry Farms, LLC, whereby FoxBarry will be the exclusive licensee and distributor of United Cannabis branded medical marijuana products in the state of California, which agreement is being filed herewith as Exhibit 10.1 and incorporated herein by reference.
    Please see the press release attached as Exhibit 99.1 for further information about this agreement.

    ITEM 7.01 REGULATION FD DISCLOSURE.On January 6, 2015, the Company issued a press release entitled “United Cannabis Corporation Signs Licensing Agreement for California with FoxBarry Farms Tribal Development Group.

    ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.(a)

    Financial Statements of Businesses Acquired

    Not Applicable.

    (b)

    Pro Forma Financial Information

    Not Applicable.

    (c)
    Shell Company Transactions

    Not Applicable.

    (d)

    Exhibits.
    
    
    
    Exhibit
    Number       Description
    
      10.1       Royalty and Consulting Services Agreement between United Cannabis
                 Corporation and FoxBarry Farms, LLC dated December 28, 2014
    
      99.1       Press Release entitled "United Cannabis Corporation Signs Licensing
                 Agreement for California with FoxBarry Farms Tribal Development
                 Group" (dated January 6, 2015)
    

     

    0 1711
    marijuana stocks

    United Cannabis Corporation Signs Licensing Agreement for California with Foxbarry Farms Tribal Development Group

    FoxBarry Farms, LLC Will Be the Exclusive Producer and Distributor for All United Cannabis Branded Products in California

    DENVER, CO / ACCESSWIRE / January 6, 2015 / United Cannabis Corporation (CNAB) (the “Company” or “United Cannabis”) today announced that it has signed a consulting and licensing agreement with FoxBarry Farms, LLC (“FoxBarry”), whereby FoxBarry will be the exclusive licensee and distributor of United Cannabis branded medical marijuana products in the State of California.

    Agreement Highlights:

    - FoxBarry will be the exclusive authorized distributor of the United Cannabis brand of medical cannabis products in the State of California

    – FoxBarry has earmarked $30 million to fund all phases of the California state-wide program

    – The Company will receive $200,000 in prepaid royalties for exclusive licensing rights in the State of California

    – United Cannabis will provide a variety of consulting services to FoxBarry-managed operations, including cultivation, harvesting, processing and sales of medical marijuana and medical marijuana infused product

    – United Cannabis will assist FoxBarry in coordinating programs with at least three different federally recognized tribes on their reservations, covering the northern, central and southern areas of California

    – The first location will be located in Northern California, and operations are expected to begin in the next 30-45 days

    – United Cannabis will receive a 15% royalty payment on the net sales derived under the agreement

    The FoxBarry group of companies provides a variety of economic development opportunities to its Native American partners. Working directly with its tribal partners, FoxBarry provides funding and management expertise in turnkey business enterprises that work within the constructs of the laws and ordinances of the tribes.

    On December 11, 2014, the Department of Justice announced that Native American tribes can grow or sell marijuana on their lands as long as they comply with the federal conditions laid out for states that have legalized medical marijuana and medical marijuana infused products.

    There are more than 560 federally recognized Indian Tribes in the US, spread over 33 states, and over 100 of them are located in California. FoxBarry is currently planning programs to serve North, Central and Southern California, and has pledged $30 million to establish the initial three sites. United Cannabis will work directly with FoxBarry to develop ordinances that comply with the various statutes in Colorado, California and Washington State as well as Federal guidelines.

    According to the National Organization for the Reform of Marijuana Laws (NORML), there are approximately 550,000 medical marijuana patients currently registered in California. With just over 1 million registered patients throughout the US, California represents well over half of the entire market.

    Earnest Blackmon, Chief Executive Officer of United Cannabis, commented on the announcement, “What a great way to start the New Year. This partnership alone gives us access to more than half of all registered marijuana patients in the country. When you factor in Colorado and our affiliates in Nevada, we have the potential to reach nearly two thirds of the registered patients in the US; the opportunity is enormous.”

    Working with FoxBarry, the Company intends to establish United Cannabis as a premier brand with the State’s medical cannabis patients. The first program will be established in Northern California, with ground breaking to occur in the next 30 days, and operations to begin in February of this year.

    Under the agreement United Cannabis has provided FoxBarry with an exclusive license to manufacture, advertise, distribute and sell United Cannabis branded marijuana, marijuana-infused products, and other authorized products, services, and articles resulting from the Company’s proprietary formulations, processes, and other intellectual property throughout the State of California. This includes branded products and services from the Company’s affiliated partnerships with DNA Genetics, EmoTek and T.H.E. Melts.

    The agreement stipulates that FoxBarry will only offer United Cannabis brand medical cannabis products and services at any facility under its management within California. These include United Cannabis’ Advanced Cannabinoid Therapy Program, or A.C.T. Now, and their patent-pending Prana Bio Nutrient Medicinals. The Company will also help FoxBarry identify and train the personnel necessary to operate the program, as well as provide ongoing staff support.

    Tony Verzura, United Cannabis’ Chief Technology Officer, added. “I am so pleased that FoxBarry chose United Cannabis’ formulations for their Medical Cannabis Program. We look forward to working with them to build the infrastructure that ensures they are able to offer California patients products and services of the same high quality and standards that our Colorado patients have come to depend on.”

    Barry Brautman, Founder and President of the FoxBarry Companies went on to say, “We are excited to team up with United Cannabis. They bring a wealth of knowledge regarding the implementation and operation of medical cannabis programs, and their products and services are highly regarded by medical cannabis patients and caregivers. This project will be beneficial to our Tribal Partners in California, who will soon have access to a proven cannabis treatment program.”

    About United Cannabis Corporation

    United Cannabis Corporation was founded to advance the use of cannabinoids in medicine through research, product development and education. The Company is dedicated to improving the lives of patients through the creation of products using only the highest quality genetics, purest extractions and most effective protocols possible. The Company’s A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provide a comprehensive solution, designed to enable physicians and patients to design, implement and monitor effective therapy protocols. For further information, please visit www.unitedcannabis.us.

    About The FoxBarry Companies

    The FoxBarry Group of companies works to generate and fund economic opportunities for its tribal partners through turn-key business enterprises that comply with tribal structures. Current Project categories include gaming development, agricultural management and consulting, fuel distribution and financial services among others. FoxBarry currently has casino projects encompassing in excess of 4,000 slot machines in four different states in various stages of development; plans to build over ten acres of greenhouses in 2015; holds fuel distribution licenses in nine states, as well as equipment financing and other financial services. For more information on the FoxBarry Companies, please visit www.foxbarry.com.

    Forward-Looking Statements

    Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

    Contact:

    Staff@UnitedCannabis.us
    Phone: 303-386-7321

    SOURCE: United Cannabis Corporation

    0 1279

    Form 8-K for UNITED CANNABIS CORP

    30-Dec-2014

    Other Events

    ITEM 8.01 OTHER EVENTS.On December 23, 2014, United Cannabis Corporation (the “Company”) paid off the outstanding balance of its $1,657,500 convertible note (the “Note”) with Typenex Co-Investment, LLC (“Typenex”) pursuant to a Payoff Letter from Typenex. The final payoff amount was $381,714.29. The Company received a letter from Typenex dated December 29, 2014, acknowledging that the payoff amount had been received by Typenex on December 23, 2014, and that the Company is released from any and all liability under the Note and the Note is deemed paid in full, cancelled and of no further force or effect. The letter from Typenex also confirmed that the Investor Notes and Warrants #2, 3, 4, 5, and 6 are now terminated and cancelled.
    Warrant # 1 is the only warrant which remains in full force and effect. A copy of this warrant was filed with the Company’s Form 8-K dated August 13, 2014.

    The payment to Typenex was funded with the proceeds from a loan from a non-affiliated investor.

     

    0 1474

    United Cannabis Corp. Partners Behind 14 Top Prizes in November’s Leading Cannabis Competitions

    DNA Genetics, Emotek, and T.H.E. Melts All Recognized Again for Excellence

    Denver, CO / ACCESSWIRE / December 10, 2014 / United Cannabis Corp. (CNAB) (the “Company” or “United Cannabis”) today announced that three of its partners, DNA Genetics, Emotek and T.H.E. Melts, were awarded top prizes at this year’s Legends of Hash, High Times’Amsterdam Cannabis Cup, and THC Championship.

    Legends of Hash, the world’s premier non-solvent extract competition, is held each November in Amsterdam. The 14 year old, invitation-only event is officiated by a select panel comprising 50 of the world’s leading non-solvent extraction experts. In 2013, T.H.E Melts took 1st and 3rd place, and this year it won 2nd Place.

    High Times‘ Cannabis Cup, the world’s preeminent cannabis festival, is also held each November in Amsterdam. Prizes are awarded based on scientific and peer review. In addition to the strenuous testing for potency (THC levels), medicinal properties (CBD levels) and contaminants, participants are reviewed by a panel of expert judges. The winners are widely viewed as the industry standard for the best cannabis strains and related products and services.

    DNA Genetics’ proprietary strains earned six of the top prizes this year, winning awards in the Satvia, Indica, Non-Solvent Extracts, and Concentrates categories. Emotek and T.H.E. Melts employed the Company’s proprietary, solvent-free, cannabis-derived terpene extraction technique to process the DNA Genetics award-winning hash entries. The combination of extraction techniques results in a more efficient delivery of cannabinoids, which can be more effective for medical applications than the use of only flowers.

    United Cannabis and Partner Cannabis Cup Winners:

    Best Sativa by a Seed Company

    1st Place: Tangie Sativa by Crockett, Top Shelf Terps, and DNA Genetics

    2nd Place: Tangie Sativa by DNA Genetics with Top Shelf Terps

    Best Indica by a Seed Company

    3rd Place: Kosher Kush Indica by DNA Genetics and Top Shelf Terps

    Best Import Hash (Concentrates) by a Seed Company

    1st Place: Super Lemon OG Import Hash by Green Wolf LA, DNA Genetics and Emotek

    3rd Place: Lemon 18 Import Hash by Emotek and DNA Genetics

    Best Neder Hash by a Seed Company

    2nd Place: Betty Ross Import Hash by T.H.E. Melts and DNA Genetics

    Third Annual THC Championship

    The Annual THC Championship, hosted by The Hemp Connoisseur magazine, is limited to Colorado competitors. The month-long competition differs from the Cannabis Cup, in that patient reviews account for 50% of the scoring, with connoisseur reviews and lab analysis each weighted at 25%. This year’s Grand Champion was processed using T.H.E. Melts’ resin extraction technology.

    United Cannabis Partner THC Championship Winners:

    THC Grand Champion

    Bruce Banner Non-Solvent Extract by RiverRock and T.H.E Melts

    Concentrates

    1st Place: Kosher Kush (DNA Genetics) Live Resin Batter by Clinic and Emotek

    3rd Place: Lemon OG Haze Live Resin by RiverRock and Emotek

    Non-Solvent Extracts

    1st Place: Bruce Banner by RiverRock and T.H.E Melts (Patient’s Choice and Connoisseur’s Choice)

    Adult Use Indica

    LA Confidential (DNA Genetics) by L’Eagle Service (People’s Choice and Connoisseur’s Choice)

    Adult Use Hybrid

    2nd Place: Lemon Skunk (DNA Genetics) by Walking Raven Dispensary

    Tony Verzura, the Company’s Chief Technology Officer, commented, “Our partners continually create the highest quality products on the market, and these awards from the leaders in the industry substantiate that claim. Not only were these strains, extracts, and concentrates recognized for their genetic properties, they also scored highly with the judges and patients across categories and events, making the wins even more meaningful.”

    Aaron T, DNA Genetics Co-founder, went on to say, “It is extremely gratifying to see our work so strongly represented in each of the categories. The November events are extremely competitive, high profile events, and we have already had a rush of inquiries from customers interested in the strains recognized this year. Our partnership with the United Cannabis team and their partners will help us ensure we can meet that demand.”

    About DNA Genetics

    DNA Genetics is a world leader in cannabis genetic research and development. Attributed with the cultivation of hundreds of cannabis strains, DNA Genetics has won more than 125 awards across the globe for their contributions to the industry, including nine for the development of the medicinal LA Confidential, the first pure Indica strain in the world to be genome sequenced and genetically mapped. United Cannabis and DNA Genetics work together, under the direction of United Cannabis, to develop new medical cannabis strains.

    About Emotek

    Emotek produces high-quality hydrocarbon oil extractors that are setting the standards in the Cannabis industry. Made from medical-grade stainless steel, the Emotek Obe Extraction Machine meets NFPA and ASME standards. Emotek extractions have won numerous Cannabis Cups as well as other similar competitions. Emotek is an exclusive United Cannabis contractor for all approved US territories.

    About T.H.E. Melts

    Trichome Heavy Extracts “T.H.E Melts” is dedicated to cannabis resin isolation through a patented process utilizing ice, water, and aggregation techniques. John Bury, owner of the T.H.E Melts, has proven himself as a world class extraction technician by winning 1st and 3rd place at Legends of Hash in 2013, 1st Place at the Secret Cup in Denver 2013, and again in 2014 with a 3rd Place US Hash High Times Award in Denver. Trichome Heavy Extracts is an exclusive United Cannabis contractor for all approved US territories.

    About United Cannabis Corporation

    United Cannabis Corporation was founded to advance the use of cannabinoids in medicine through research, product development and education. The Company is dedicated to improving the lives of patients through the creation of products using only the highest quality genetics, purest extractions and most effective protocols possible. The Company’s A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provide a comprehensive solution designed to enable physicians and patients to design, implement and monitor effective therapy protocols.

    For further information, please visit www.unitedcannabis.us.

    Forward-Looking Statements

    Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

    Contact:

    Lorin Cohen
    +1 (720) 319-7519


    SOURCE:
    United Cannabis Corp.

    0 1601

    Chief Technical Officer Tony Verzura and Chad Ruby Chief Operating Officer of United Cannabis Corp. Featured in a New Interview With SmallCapVoice.com

    AUSTIN, Texas, Nov. 10, 2014 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. announced today that a new audio interview with United Cannabis Corp. (CNAB) a leader in the medical cannabis industry by offering patient driven solutions intent on improving biomedical and pharmaceutical pursuits thru the use of Cannabis based research, products and services., is now available. The interview with the Company’s CTO and COO can be heard athttp://smallcapvoice.com/blog/11-5-14-smallcapvoice-interview-with-united-cannabis-corp-cnab

    SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visithttp://www.smallcapvoice.com/services.html.

    About United Cannabis Corporation

    United Cannabis Corporation was founded to advance the use of cannabinoids in medicine through research, product development and education. The Company is dedicated to improving the lives of patients through the creation of products using only the highest quality genetics, purest extractions and most effective protocols possible. The Company’s A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provide a comprehensive solution designed to enable physicians and patients to design, implement and monitor effective therapy protocols.

    For further information, please visit www.unitedcannabis.us.

    Forward-Looking Statements

    Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

    Contact:
    Lorin Cohen
    1-720-319-7519
    For SmallCapVoice.com:
    Stuart T. Smith
    512-267-2430
    info@smallcapvoice.com

    0 1933

    United Cannabis Corporation Announces Venture With Jamaica-Based Cannabinoid Research & Development Company Limited

    DENVER, CO, Oct 02, 2014 (Marketwired via COMTEX) — United Cannabis Corporation (otcqb:CNAB) (the “Company” or “United Cannabis”) today announced that it has participated with a small group of Jamaicans to form a Jamaican corporation named Cannabinoid Research & Development Company Limited (“CRD” or the “Venture”). The Company owns a fifty percent interest in CRD. The Company participated in the formation of CRD in order to further the Company’s mission of advancing the use of cannabis in medical therapies through biomedical and pharmaceutical research and development, within Jamaica. The Venture has identified a 30,000 square foot facility in Kingston’s industrial zone to serve as its corporate headquarters, but a lease has not yet been signed.

    Despite its association with Jamaica and its culture, marijuana has actually been illegal there since the 1961 United Nations Single Convention on Narcotic Drugs. Ironically, the Jamaican government has been hesitant to decriminalize marijuana until now for fear of triggering hinted-at sanctions from Washington. That pressure has diminished in conjunction with the trend toward legalization in the US, and today the Jamaican government announced legislation has been drafted to decriminalize marijuana for medical purposes by the end of 2014.
    Commenting on the announcement, Earnest Blackmon, Chief Executive Officer of United Cannabis, stated, “I have visited Jamaica during my 20-year career cultivating medical cannabis, and have long championed their decriminalization of marijuana. With that milestone clearly on the horizon, we formed CRD to formally establish our presence in Jamaica and begin preparing an application for a provisional license so we will be ready to apply the minute submissions are being accepted.”

    Tony Verzura, Chief Technical Officer of United Cannabis, added, “We could not be happier about the news from Jamaica. The variety of strains cultivated there, along with the benefits of the Caribbean environment provide a wealth opportunity for discovery and growth. Our 50% ownership in CRD affords us with immediate access to the local resources and insight to the intricacies of the infrastructure, giving us real momentum as we enter the Jamaican market.”

    Mr. Mark Richardson, Chief Technology Officer of Cannabinoid Research & Development Company Limited, stated, “I am excited to begin working with Tony, Earnie, and the rest of the United Cannabis Team. The work they have done in Colorado is on the cutting edge. Not only do they bring an extensive knowledge of the cannabis plant and its properties, but their ability to leverage technology and incorporate systems within the breeding process will be invaluable as we seek to pursue the vast opportunities here in Jamaica.”

    Mr. Richardson went on to say, “While marijuana cultivation was deemed illegal during the past 50 years, the unrestrained cultivation by some factions resulted in the degradation of several of Jamaica’s original strains. One of the goals of CRD is to help restore the purity of those strains and standardize the breeding process to ensure this does not happen again.”

    ABOUT CRD

    Cannabinoid Research and Development Company Limited was founded this year by a small group of Jamaican cannabis advocates, with the cooperation of the Company, who felt that it was high time for as said in Jamaica, ‘freeing up the weed’. These desires were further buttressed by the government signaling through comments made by several Ministers this week that the Jamaican government has drafted legislation to establish medical marijuana and industrial hemp industries in Jamaica. In closing, we salute the small farmers who they through their sacrifices, paying the ultimate price of incarceration, persecution and the separation from loved ones. It is the spirit, hope, dreams and aspirations of these people that is embodied in the dream and justification for CRD today.

    About United Cannabis Corporation United Cannabis Corporation was founded to provide leadership for the medical cannabis industry by offering patient driven solutions intent on improving biomedical and pharmaceutical pursuits thru the use of cannabis-based research, products and services.

    For further information, please visit www.unitedcannabis.us

    Forward-Looking Statements

    Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

    Contact:
    MZ North America
    Matthew Selinger
    SVP
    Tel: +1-949-298-4319
    Email: mselinger@mzgroup.us
    Web: www.mzgroup.us
    SOURCE: United Cannabis Corporation

    (C) 2014 Marketwire L.P. All rights reserved.

    Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

    We are your #1 source for all things Marijuana Stocks, Subscribe Below!

    Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
    Ad Placements